- Tuesday's Heavy Dose of Data to Dictate 'Risk' Behavior
- World's Largest Share Issue Priced at Deep Discount
- Obama says Boosting US Jobs is Top Priority
- GM to Cut up to 9,500 Jobs in Europe
- Playboy to Outsource Most Magazine Operations: Report
- Why the Dollar Will Likely Stay Weak for Some Time
- Appeals Court Denies Microsoft's Alcatel Petition
- HP Comes in As Expected; Is It Time to Buy?
- Cramer: What Monday’s Housing Number Really Means
- Can Murdoch Help Bing Challenge Google and Shift the Content Equation?
- HP's Mark Hurd
- HP Comes in As Expected; Is It Time to Buy?
- 9 Stocks That Play Rising Water Costs: Strategists
- Weis' Deal Likely Won't Change Big Money Contracts
- Gold Prices Can Double in 3 Years: Portfolio Manager
- Nov. 23: Unusual Volume Leaders
- Help Wanted—Please Run $4 Billion University
- Apple Comes to AT&T's Rescue
MOST SHARED
- The 'Real' Jobless Rate: 17.5% Of Workers Are Unemployed
- Why Amazon Rules Retail
- Wave of Debt Payments Facing US Government
- Paul: Audit the Fed
- China Eastern to Complete Shanghai Air Buy by End '09
- The Social Media Gaming Threat
- JAL Slides to Record Low on Bankruptcy Jitters
- Gold Will Collapse Like Oil Did in 2008: Charts
- Prepare For Large Decline In Stocks, Next Year?
- Nielsen Ratings Coming to Video Games
Text Size 
The new Merck becomes the world's second-biggest drugmaker overnight, and it's boasting a fat wallet to fund future deals.
That's after the maker of vaccines and cholesterol and diabetes drugs bought Schering-Plough [SGP
Loading...
()
] yesterday for $41.1 billion.
 |
AP |
Merck [MRK
Loading...
()
] leapfrogged from No. 8 to No. 2 in the industry by revenue.
The company has about $8 billion in cash and investments and plans to keep investing in deals for rights to new drugs.
Merck says combining the companies — and slimming down the resulting staff of 106,000 employees — will save about $3.5 billion a year after 2011.
But it expects the acquisition to boost profits slightly by next year and is forecasting profit growth in the high single digits for the next several years.
- The show attracts a big TV audience every year, but this year it may take on even more importance.
- …you'll want to be prepared. Tips for getting the most out of the post-Thanksgiving shopping frenzy.
- Congressman Ron Paul explains to Squawk Box why he’s pushing legislation to audit the Federal Reserve.
- CNBC’s Phil LeBeau took a test drive of GM’s flagship electric car. Here’s what he thought of the Volt.
- The energy company Power Efficiency is building tools that regulate the power electric motors use.
- CNBC’s technology reporter Jim Goldman guides you through the best gadgets to buy this holiday season.
Data is a real-time snapshot *Data is delayed at least 15 minutes